Search
Search Results
##search.searchResults.foundPlural##
-
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
857PDF: 540HTML: 304 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
7796PDF: 3163HTML: 1167 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1855PDF: 764HTML: 204 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
885PDF: 555HTML: 2176Cover Letter: 167 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3139PDF: 900HTML: 2923 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
785PDF: 520HTML: 4002 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3806PDF: 1428HTML: 9169Untitled: 255Untitled: 158Untitled: 148Untitled: 143Untitled: 162Untitled: 315 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2533PDF: 903HTML: 3571 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2278PDF: 876HTML: 477 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7748PDF: 691HTML: 191 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2428PDF: 808HTML: 8786Efremov 1: 204Efremov 2: 161 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1735HTML: 1344PDF: 1011 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4504PDF: 2706HTML: 2223 -
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1418PDF: 1112HTML: 169 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2346HTML: 249PDF: 814 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1179PDF: 874HTML: 260Suppl. Figure: 171Suppl. Tables: 188 -
WHAT ARE FUNGAL INFECTIONS?
4005PDF: 2296HTML: 27537de Pauw: 205 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
517PDF: 321HTML: 71 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1414PDF: 888HTML: 207 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1723PDF: 776HTML: 10202Figures 1,2,3: 150 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
921PDF: 510HTML: 7794 -
-
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1343PDF: 629HTML: 1362cover letter: 187 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1196PDF: 450HTML: 18539Figure 1: 151Figure 2: 136Figure 3: 152Figure 4: 185Figure 5: 155 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
913PDF: 657HTML: 209 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
800PDF: 477HTML: 1282 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1148PDF: 562HTML: 197







